Chemours Co
$ 11.96
-1.08%
29 Dec - close price
- Market Cap 1,792,708,000 USD
- Current Price $ 11.96
- High / Low $ 12.00 / 11.73
- Stock P/E N/A
- Book Value 1.99
- EPS -2.13
- Next Earning Report 2026-02-17
- Dividend Per Share $0.68
- Dividend Yield 5.58 %
- Next Dividend Date -
- ROA 0.03 %
- ROE -0.66 %
- 52 Week High 19.38
- 52 Week Low 9.01
About
Chemours Co (Ticker: CC) is a leading global provider of high-performance chemical solutions, specializing in areas such as titanium technologies and fluoroproducts. Operating across North America, Europe, Asia Pacific, the Middle East, Africa, and Latin America, the company has established a broad market presence and diverse customer base. Headquartered in Wilmington, Delaware, Chemours is dedicated to sustainability and innovation, leveraging advanced technologies to create impactful products while upholding a strong commitment to environmental stewardship. With a focus on delivering value through its specialty chemical solutions, Chemours is well-positioned for growth in multiple key industries.
Analyst Target Price
$15.56
Quarterly Earnings
| Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2025-11-04 | 2025-08-05 | 2025-05-06 | 2025-02-18 | 2024-11-04 | 2024-08-01 | 2024-04-30 | 2024-03-27 | 2023-10-26 | 2023-07-27 | 2023-04-27 | 2023-02-09 |
| Reported EPS | 0.2 | 0.58 | 0.13 | 0.11 | 0.4 | 0.38 | 0.32 | 0.31 | 0.63 | 1.1 | 0.98 | -0.6465 |
| Estimated EPS | 0.24 | 0.46 | 0.2 | 0.16 | 0.28 | 0.57 | 0.18 | 0.25 | 0.69 | 1.07 | 0.47 | 0.08 |
| Surprise | -0.04 | 0.12 | -0.07 | -0.05 | 0.12 | -0.19 | 0.14 | 0.06 | -0.06 | 0.03 | 0.51 | -0.7265 |
| Surprise Percentage | -16.6667% | 26.087% | -35% | -31.25% | 42.8571% | -33.3333% | 77.7778% | 24% | -8.6957% | 2.8037% | 108.5106% | -908.125% |
Next Quarterly Earnings
| Dec 2025 | |
|---|---|
| Reported Date | 2026-02-17 |
| Fiscal Date Ending | 2025-12-31 |
| Estimated EPS | 0.01 |
| Currency | USD |
Previous Dividend Records
| Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Payment Date | 2025-12-15 | 2025-09-12 | 2025-06-16 | 2025-03-14 | 2024-12-16 | 2024-09-13 | 2024-06-14 | 2024-03-15 | 2023-12-15 | 2023-09-15 |
| Amount | $0.0875 | $0.0875 | $0.0875 | $0.25 | $0.25 | $0.25 | $0.25 | $0.25 | $0.25 | $0.25 |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: CC
2025-12-29 15:09:27
The global Titanium(IV) Chloride market, valued at US$9.93 billion in 2024, is projected to reach US$12.35 billion by 2031 with a CAGR of 3.2% between 2025 and 2031, according to a report by QY Research. This growth is driven by its critical role in producing titanium metal and titanium dioxide. Key industry players include Chemours, Tronox, Venator, and INEOS, with the market segmented by type (High Titanium Slag, Rutile) and application (Titanium Dioxides Manufacturing, Precursor of Titanium Metals and Powders, Catalysts).
2025-12-25 22:34:48
Despite a significant three-year share price slide, Chemours (NYSE: CC) appears undervalued based on two key metrics: Discounted Cash Flow (DCF) analysis and Price to Sales (PS) ratio. The DCF model suggests the stock is 71.0% undervalued, projecting a substantial recovery in free cash flow, while its PS ratio of 0.31x is well below industry averages and its own Fair Ratio of 0.80x. The company's valuation is influenced by ongoing environmental liabilities related to PFAS chemicals and efforts to streamline its product portfolio.
2025-12-22 18:09:14
The global Fluorochemicals Market is projected to grow at a CAGR of 7.4% from 2024 to 2033, reaching $58.4 billion by 2033, up from $32.9 billion in 2024. Key market drivers include demand for HVAC, electric vehicles, pharmaceuticals, and chemical resistance, facing challenges from environmental regulations and PFAS concerns. Asia-Pacific is identified as both the dominating and fastest-growing region.
2025-12-22 14:15:00
Alta Fundamental Advisers has made a significant contrarian investment in The Chemours Company (NYSE: CC), acquiring 800,000 shares and 200,000 call options despite the stock's recent 32% decline. This move signals a belief that the market has mispriced Chemours following accounting scandals, dividend cuts, and environmental litigation, particularly after a landmark PFAS settlement provided a clearer financial outlook for the company. The investment by Alta suggests a potential turning point for Chemours and could serve as a bellwether for how the financial markets price the risks associated with "forever chemical" litigation.
2025-12-19 13:10:16
Damián Gumpel, head of Chemours' titanium dioxide business, is leaving the company after only starting at the beginning of the year. Michael Foley is slated to take over the role in February 2026, with CEO Denise Dignam heading the division in the interim. This departure follows a difficult year for Chemours, marked by underperforming titanium dioxide business and significant PFAS-related compensation payments.
2025-12-18 04:09:29
RBC Capital analyst Arun Viswanathan has reiterated a Buy rating on Chemours Company (CC) with a $16.00 price target. This comes as the company continues to show a "Moderate Buy" consensus among analysts, with an average price target of $16.13. The report notes Chemours' recent Q3 earnings, which included $1.5 billion in revenue and a net profit of $60 million.
